ask="1.75"
ask_size="5000"
average_daily_volume="173063"
bid="1.44"
bid_size="1900"
book_value="0.39"
change="+0.00"
change_from_200_day_moving_average="-0.14"
change_from_50_day_moving_average="-0.08"
change_from_52_week_high="-0.52"
change_From_52_week_low="0.66"
change_in_percent="+0.00%"
close="1.46"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-0.25"
ebitda="-12.06M"
eps_estimate_current_year="-0.14"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.08"
ex_dividend_date="6/24/2005"
float_shares="35270000"
high="1.48"
high_52_weeks="1.98"
last_trade_date="3/1/2017"
last_trade_price="1.46"
last_trade_size="574"
last_trade_time="4:00pm"
low="1.46"
low_52_weeks="0.80"
market_capitalization="98.64M"
moving_average_200_day="1.60"
moving_average_50_day="1.54"
name="Biolase
Inc."
notes="N/A"
one_year_target_price="2.00"
open="1.47"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-8.69%"
percent_change_from_50_day_moving_average="-5.19%"
percent_change_from_52_week_high="-26.26%"
percent_change_from_52_week_low="+82.50%"
previous_close="1.46"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.78"
price_per_sales="1.88"
revenue="52.44M"
shares_outstanding="67565000"
short_ratio="7.30"
stock_exchange="NCM"
symbol="BIOL"
volume="60048"
weeks_range_52="0.80 - 1.98"
